Ravi Vij

Saint Louis University — Spain

Medicine · Health Sciences

74h-index27.7kcitations959works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(655), Protein Degradation and Inhibitors(246), Hematopoietic Stem Cell Transplantation(147), Acute Myeloid Leukemia Research(141), Chronic Lymphocytic Leukemia Research(101)

Publications958 total

Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma
Blood Cancer Discovery·2025Open Access
Supplementary Figures from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S3 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S2 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S1 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S6 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S4 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Perioperative Glucagon-like Peptide-1 Receptor Agonist Use Is Associated With Lower Pseudoarthrosis Rates Following Long-Segment Spinal Deformity Correction: A Propensity-Matched Analysis
Global Spine Journal·2025Open Access
Pilot study of cell-free DNA (cfDNA) for measurable residual disease monitoring following autologous hematopoietic cell transplant in multiple myeloma
Blood·2025Open Access
Feasibility of risk classification with newly proposed international myeloma working group (IMWG) high-risk definition: A single-center analysis using natural language processing
Blood·2025Open Access
Motixafortide + G-CSF hematopoietic stem cell mobilization in patients with multiple myeloma following quadruplet induction therapy
Blood·2025Open Access
Molecular profiling and kinetics of circulating multiple myeloma cells (CMMCs) predict resistance to bispecific antibodies (BsAbs) in relapsed and/or refractory multiple myeloma (RRMM)
Blood·2025Open Access
Cellular senescence associated with aging and chemotherapy exposure primes bone marrow for immune dysfunction and myeloma persistence
Blood·2025Open Access
An immune proteomic atlas of 300 million bone marrow cells reveals prognostic cell states in multiple myeloma
Blood·2025
Combinations of high risk cytogenetic events in multiple myeloma drive distinct immune remodeling patterns and worse outcomes
Blood·2025Open Access
Spatial biomarkers of CAR-T treatment response in relapsed refractory multiple myeloma
Blood·2025Open Access
Correlative biomarker analyses of etentamig in patients with Relapsed/Refractory multiple myeloma (RRMM) at optimal dose support its potential to maximize T-cell activity with rapid and transient proinflammatory cytokine responses
Blood·2025Open Access
Convenience Versus Continuity: A Pilot Study of Care Transfer to a Satellite Clinic for Patients With Plasma Cell Dyscrasias
Cancer Control·2025Open Access
A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate E-Selectin Inhibition with Uproleselan to Reduce Gastrointestinal Toxicity During Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Transplantation and Cellular Therapy·2025· 1 citedOpen Access
page 1 of 48Next →

Frequent Co-authors

Sundar Jagannath(14), Sagar Lonial(13), John F. DiPersio(10), Andrzej Jakubowiak(9), David S. Siegel(9), Kenneth C. Anderson(8), Parameswaran Hari(8), Peter Westervelt(8), Philippe Moreau(7), A. Keith Stewart(6), Paul G. Richardson(6), Sergio Giralt(6), Steven M. Devine(6), Luciano J. Costa(6), Nizar J. Bahlis(6), Craig C. Hofmeister(5), Natalie S. Callander(5), Mary M. Horowitz(5), Jonathan L. Kaufman(5), Geoffrey L. Uy(5)